You are reading the web version of STAT Health Tech. This is your guide to how technology is transforming life sciences. Sign up to have this newsletter delivered to your inbox every Tuesday and Thursday.
Opportunities to invest in generative AI health Care
Open AI”■ ChatGPT has sparked a boom in interest in how generative AI technology will transform healthcare, leading to already high-profile investments.
New report by venture capitalists GSR Ventures and Maverick Ventures Explore new technology possibilities across the healthcare ecosystem. Interestingly, the author’s chart uses a matrix based on the complexity of the application and its level of adoption. Many of the simpler and more advanced opportunities, such as taking medical notes and communicating with patients, have already received considerable attention. However, applications in emerging fields such as personalized medicine are difficult and are still in their early stages.
The report also details the challenges faced by startup founders. Some are established weaknesses of the healthcare system, such as long sales cycles, while others are unique to this AI moment.like a giant player Google OpenAI and OpenAI have made implementing AI as easy as calling an API, the authors write, “as these models become more popular due to their efficiency and accuracy, startups are lining up the technology within the industry.” We face the challenge of maintaining our defenses.”
Can AI provide a lifeline to the 988?
Counselors who answer calls to the crisis line are carefully trained to manage sensitive situations and complete important checks such as suicide risk screening. Job quality is reviewed randomly, but this process is inefficient and can fail to detect problems. And since the launch of 988 Lifeline last year, the crisis line has faced a surge in demand, making the challenge even more difficult.
protocol call serviceoperate a crisis line; and Lissenis a startup developing an AI that automatically reviews health behavior records and has partnered to see if technology can be used to improve quality. Both companies recently won his $2 million grant from an international organization. National Institute of Mental Health Develop and test AI to check whether counselors are properly screening for suicide.
Find out more about my story here.
A company aims to analyze AI options
Buying AI tools in healthcare is a lot like buying a used car. Especially in the eyes of a charismatic salesperson, it’s hard to tell the clunky from the rugged model.but newly formed dandelion health They say it helps customers take a deeper look inside. The New York-based company collected data from three disparate healthcare systems in Texas, California, and South Dakota to independently test its algorithms for generalizability and susceptibility to bias. The company’s first pilot, free of charge, will focus on algorithms that use electrocardiograms to predict heart disease, a hot area of AI development.
You can read more about Casey Ross’s article on STAT here.
MRI Enhancer Firm Earns $30 Million
MRI technology company N Vision Imaging, The Germany-based company announced Thursday that it has secured $30 million in Series A funding. It also earned $19.5 million from the German government. NVision has developed a metabolic agent that is injected into patients undergoing MRI, enabling more sensitive and detailed cancer diagnosis and analysis. For example, doctors might be able to find cancerous tissue based on how it interacts with sugars, rather than simply scanning images of tumors.
“It increases the sensitivity, so even if the morphology looks normal, the metabolism is different.” Sera BroshCEO of NVision told STAT’s Lizzy Lawrence.
Brosh plans to use the money to build and deploy a system that includes an injectable and a machine that amplifies its magnetic signal. We are partnering with Siemens Hellnears We plan to install the system in 50 cancer centers by 2025. “We are an R&D focused company,” said Brosh. “We have been working on this for over six years. The key is getting the system to the strongest cancer centers in the world.”
FTC Blames Genetic Testing Firm Over Data Policy
of Federal Trade Commission Reached settlement with genetic testing company 1Health.io On allegations of storing genetic data and health records in publicly accessible locations AWS It took advantage of cloud storage and tricked consumers with data privacy and the ability to delete data. The company, also known as vitagen, sold DNA testing kits that provide consumers with information about their ancestry and health.
As part of the settlement, the company will have to pay a fine of $75,000, which the FTC will use to reimburse consumers. 1Health.io It also requires adherence to standard data privacy and security practices, such as obtaining informed consent when sharing data with third parties, and a 20-year biennial data security assessment from a third-party assessor. can be
